Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Asia Pacific Wire & Cable
APWC
$61.8M
| $91K | ﹤0.01% |
72,400
-600
| -0.8% | -$795 |
|
3327
One Stop Systems
OSS
$327M
| $91K | ﹤0.01% |
43,200
+4,700
| +12% | +$9.45K |
|
3328
Exagen
XGN
$160M
| $91K | ﹤0.01% |
+45,488
| New | +$78.7K |
|
3329
Biodesix
BDSX
$251M
| $90K | ﹤0.01% |
2,440
+1,370
| +128% | +$43K |
|
|
ASLN
3330
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $90K | ﹤0.01% |
21,600
+17,417
| +416% | +$131K |
|
3331
Elutia
ELUT
$38M
| $89K | ﹤0.01% |
41,177
+11,661
| +40% | +$19.1K |
|
3332
Vertical Aerospace
EVTL
$107M
| $89K | ﹤0.01% |
+12,987
| New | +$115K |
|
|
MYND
3333
Mynd.ai
MYND
$18.4M
| $89K | ﹤0.01% |
+16,044
| New | +$147K |
|
3334
FreightCar America
RAIL
$243M
| $89K | ﹤0.01% |
+32,800
| New | +$82.8K |
|
|
AIM
3335
AIM ImmunoTech
AIM
$7.17M
| $89K | ﹤0.01% |
2,022
+97
| +5% | +$4.52K |
|
3336
Recon Technology
RCON
$2.5M
| $88K | ﹤0.01% |
20,874
-14,332
| -41% | -$70.6K |
|
|
MTEM
3337
DELISTED
Molecular Templates, Inc.
MTEM
| $88K | ﹤0.01% |
23,653
+7,895
| +50% | +$41.3K |
|
3338
Arts-Way Manufacturing Co
ARTW
$13.3M
| $87K | ﹤0.01% |
42,174
-14,500
| -26% | -$30K |
|
3339
Oragenics
OGEN
$2.42M
| $87K | ﹤0.01% |
514
+63
| +14% | +$7.46K |
|
3340
Laird Superfood
LSF
$48.2M
| $86K | ﹤0.01% |
94,100
+1,900
| +2% | +$1.7K |
|
|
CONN
3341
DELISTED
Conn's Inc.
CONN
| $86K | ﹤0.01% |
19,312
+4,900
| +34% | +$16.2K |
|
|
EZGO
3342
EZGO Technologies
EZGO
$2.84M
| $85K | ﹤0.01% |
+5
| New | +$82.2K |
|
|
NUTX
3343
Nutex Health
NUTX
$1.18B
| $85K | ﹤0.01% |
3,145
+2,986
| +1,878% | +$93.1K |
|
3344
Universal Safety Products Inc
UUU
$10.8M
| $85K | ﹤0.01% |
+51,185
| New | +$143K |
|
|
RNTX
3345
Rein Therapeutics
RNTX
$67.4M
| $85K | ﹤0.01% |
28,019
+9,055
| +48% | +$17.7K |
|
3346
American Shared Hospital Services
AMS
$10.2M
| $84K | ﹤0.01% |
35,500
-24,488
| -41% | -$58.9K |
|
|
FNCB
3347
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $84K | ﹤0.01% |
12,300
-426
| -3% | -$2.6K |
|
|
NURO
3348
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| $84K | ﹤0.01% |
23,432
+19,674
| +524% | +$82.7K |
|
3349
Genprex
GNPX
$2.46M
| $83K | ﹤0.01% |
+8
| New | +$92.3K |
|
3350
POET Technologies
POET
$1.54B
| $83K | ﹤0.01% |
+88,700
| New | +$155K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.